Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Zhejiang DTRM Biopharma
OHSU Knight Cancer Institute
Gilead Sciences
Mayo Clinic
Mayo Clinic
Mayo Clinic
University of California, Davis
SWOG Cancer Research Network
City of Hope Medical Center